Suppr超能文献

蛋白激酶Cα(PKCα)以p53依赖的方式调节携带程序性死亡配体1(PDL1)的小细胞外囊泡的分泌。

PKCα regulates the secretion of PDL1-carrying small extracellular vesicles in a p53-dependent manner.

作者信息

Zhang Ren, Liao Weilin, Chen Xi, Wang Junyi, Li Jiaqi, Chen Geer, Wu Weiyu, Wang Xiaoxuan, Zhang Yao, Chen Ziyu, Zhu Xiaoyu, Lin Zicong, Zhu Yizhun, Ma Lijuan, Yu Haijie

机构信息

School of Pharmacy, Faculty of Medicine & State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.

Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.

出版信息

Cell Death Dis. 2025 Jan 14;16(1):19. doi: 10.1038/s41419-025-07341-5.

Abstract

Small extracellular vesicles (sEVs), carrying PD-L1, have been implicated in immune evasion and tumor progression. However, understanding how PD-L1 sEVs are secreted still needs to be improved. We found that the secretion dynamics of PD-L1 sEVs is similar to that of other sEVs. Intracellular calcium and the associated downstream PKC signaling plays pivotal roles in releasing PD-L1 sEVs in non-small cell lung cancer cells (NSCLC). Particularly, we observed that knocking down PKCα has profound impacts on PD-L1 sEVs secretion, especially in the resting state and in the activated state, when induced by an intracellular calcium rise. Furthermore, our study revealed that PKCα regulates PD-L1 expression and PD-L1 sEVs secretion by influencing STAT1 phosphorylation and nuclear translocation in a p53-dependent manner. Notably, p53 can regulate STAT1 phosphorylation and nuclear localization, but it does not affect PKCα expression. This suggests that PKCα plays a significant role in regulating PD-L1 expression. Our findings suggest that targeting PKCα to modulate PD-L1 dynamics in NSCLC may be a promising therapeutic strategy to enhance the efficacy of immunotherapeutic interventions.

摘要

携带程序性死亡受体配体1(PD-L1)的小细胞外囊泡(sEVs)与免疫逃逸和肿瘤进展有关。然而,对PD-L1 sEVs分泌方式的了解仍有待完善。我们发现,PD-L1 sEVs的分泌动力学与其他sEVs相似。细胞内钙及相关的下游蛋白激酶C(PKC)信号在非小细胞肺癌(NSCLC)细胞释放PD-L1 sEVs过程中起关键作用。特别地,我们观察到敲低PKCα对PD-L1 sEVs的分泌有深远影响,尤其是在静息状态和细胞内钙升高诱导的激活状态下。此外,我们的研究表明,PKCα通过以p53依赖的方式影响信号转导和转录激活因子1(STAT1)的磷酸化和核转位,来调节PD-L1的表达及PD-L1 sEVs的分泌。值得注意的是,p53可调节STAT1的磷酸化和核定位,但不影响PKCα的表达。这表明PKCα在调节PD-L1表达中起重要作用。我们的研究结果表明,在NSCLC中靶向PKCα以调节PD-L1动态变化可能是一种有前景的治疗策略,可提高免疫治疗干预的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d54/11733117/7ddc3051c54d/41419_2025_7341_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验